ArticleJournal of immunotherapy and precision oncology2025

Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study.

Aung Naing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.